Artoss GmbH
Biocomposites is an international medical device company based in Keele, UK, specializing in engineering, manufacturing, and marketing innovative calcium compound and polymer products for infection management in bone and soft tissue. With over 30 years of experience, the company operates globally across Europe, USA, Canada, China, and India, and its products are used in over 1 million procedures annually in more than 100 countries. Biocomposites focuses on regenerating bone and targeting infection risks across various clinical specialties, including musculoskeletal infection, orthopaedics, trauma, spine, foot and ankle, podiatry, and sports injuries. The company has received prestigious awards such as the Queen’s Awards for Enterprise in Innovation and International Trade, and has developed proprietary technologies supported by over 100 grants and registrations of IP.
Industries
Nr. of Employees
large (251-1000)
Artoss GmbH
Patents
Implantable pharmaceutical composition prepared from components consisting of calcium sulfate alpha-hemihydrate, vancomycin and gentamicin
US-12133862-B2
View DetailsMethod to introduce an implantable device to fill a bone void whilst minimising pressurisation
US-10390954-B2
View Details
Implantable pharmaceutical composition prepared from components consisting of calcium sulfate alpha-hemihydrate, vancomycin and gentamicin
US-12133862-B2
View DetailsMethod to introduce an implantable device to fill a bone void whilst minimising pressurisation
US-10390954-B2
View DetailsProducts
STIMULAN
Absorbable calcium sulfate matrix intended for filling dead space and for use as a local antibiotic carrier in bone and soft-tissue infection management.
genex
Synthetic resorbable bone graft substitute designed to support natural bone healing and be fully resorbed.
NanoBone
Nano-structured bone graft technology added to the product portfolio for bone regeneration and spinal applications.
Biosteon
Osteoconductive calcium phosphate composite designed for improved strength retention and bone-bonding potential.
Allogran-R
Polycrystalline porous calcium phosphate bone substitute intended for use in trauma and spine procedures.
Bilok
Synthetic calcium composite interference screws developed for arthroscopic sports-injury procedures.
STIMULAN
Absorbable calcium sulfate matrix intended for filling dead space and for use as a local antibiotic carrier in bone and soft-tissue infection management.
genex
Synthetic resorbable bone graft substitute designed to support natural bone healing and be fully resorbed.
NanoBone
Nano-structured bone graft technology added to the product portfolio for bone regeneration and spinal applications.
Biosteon
Osteoconductive calcium phosphate composite designed for improved strength retention and bone-bonding potential.
Allogran-R
Polycrystalline porous calcium phosphate bone substitute intended for use in trauma and spine procedures.
Bilok
Synthetic calcium composite interference screws developed for arthroscopic sports-injury procedures.
Services
Online portal providing marketing resources, e-learning and sales tools for regional distributor representatives.
Provision of clinical case studies, procedure-focused content and a publication library to support clinician education and evidence review.
Sponsorship and execution of clinical studies for device evaluation, including Phase II trials for drug-device combination products.
Online portal providing marketing resources, e-learning and sales tools for regional distributor representatives.
Provision of clinical case studies, procedure-focused content and a publication library to support clinician education and evidence review.
Sponsorship and execution of clinical studies for device evaluation, including Phase II trials for drug-device combination products.
Expertise Areas
- Local antibiotic delivery for bone and soft tissue
- Biomaterials engineering of calcium compounds and polymers
- Resorbable bone graft substitutes and bone regeneration
- Clinical trial execution for implantable devices and drug-device combinations
Key Technologies
- Absorbable calcium sulfate antibiotic matrices
- Synthetic resorbable bone graft formulations
- Calcium phosphate composite materials
- Surface chemistry and crystal engineering of biomaterials
News & Updates
Expansion into new geographies and enhanced approval for STIMULAN to treat bacterial infection.
Recognition for excellence in innovation and international trade by Her Majesty The Queen.
NanoBone products now approved for intervertebral body fusions with FDA-cleared devices.
Queen’s Award for Enterprise in Innovation
Awarded for innovative calcium compound devices that regenerate and repair bone and soft tissue.
Queen’s Award for Enterprise in International Trade
Recognized for global sales growth and international presence.
Expansion into new geographies and enhanced approval for STIMULAN to treat bacterial infection.
Recognition for excellence in innovation and international trade by Her Majesty The Queen.
NanoBone products now approved for intervertebral body fusions with FDA-cleared devices.
Queen’s Award for Enterprise in Innovation
Awarded for innovative calcium compound devices that regenerate and repair bone and soft tissue.
Queen’s Award for Enterprise in International Trade
Recognized for global sales growth and international presence.